Damloran Pharmaceutical (XTEH:DAML1) Pretax Margin %: % (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Pretax Margin %?

Damloran Pharmaceutical XTEH:DAML1 27 Pretax Margin % is % as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Damloran Pharmaceutical's Pre-Tax Income for the six months ended in . 20 was IRR0.00 Mil. Damloran Pharmaceutical's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Damloran Pharmaceutical's pretax margin for the quarter that ended in . 20 was %.

The historical rank and industry rank for Damloran Pharmaceutical's Pretax Margin % or its related term are showing as below:


XTEH:DAML1's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.28
* Ranked among companies with meaningful Pretax Margin % only.

Damloran Pharmaceutical  (XTEH:DAML1) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Damloran Pharmaceutical Pretax Margin % Related Terms


Damloran Pharmaceutical Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Pretax Margin % Chart

Damloran Pharmaceutical Annual Data
Trend
Pretax Margin %

Damloran Pharmaceutical Semi-Annual Data
Pretax Margin %

XTEH:DAML1 vs IMNPQ: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Damloran Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Damloran Pharmaceutical Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Damloran Pharmaceutical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Damloran Pharmaceutical's Pretax Margin % falls into.


XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Damloran Pharmaceutical's Pretax Margin for the fiscal year that ended in . 20 is calculated as

Pretax Margin=Pre-Tax Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Damloran Pharmaceutical's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin=Pre-Tax Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Pretax Margin % of % as of . 20. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's Pretax Margin % too high?
Damloran Pharmaceutical's current Pretax Margin % is %. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Pretax Margin % compare to IMNPQ?
Damloran Pharmaceutical's Pretax Margin % of % can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Damloran Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Damloran Pharmaceutical's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Pretax Margin % of %. The current Pretax Margin % is %. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Pretax Margin % is % as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price